Related Experiment Video
Updated: May 26, 2026

09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
The PFA-100 ® does not predict delta-granule platelet storage pool deficiencies
J L Sladky1, J Klima, L Grooms
1College of Medicine, The Ohio State University, Columbus, OH, USA.
Summary
The platelet function analyzer (PFA-100®) does not reliably detect delta-granule platelet storage pool deficiencies (δ-PSPD). This common bleeding disorder requires further diagnostic evaluation beyond PFA-100® testing alone.
Area of Science:
- Hematology
- Platelet Function Analysis
- Congenital Bleeding Disorders
Background:
- Delta-granule platelet storage pool deficiencies (δ-PSPD) are common mild bleeding disorders.
- The PFA-100® is a widely used screening tool for bleeding disorders.
- Previous studies on PFA-100® in platelet disorders had limited patient numbers and diagnostic specificity.
Purpose of the Study:
- To investigate the utility of the PFA-100® in detecting δ-PSPD.
- To determine the correlation between PFA-100® results and platelet electron microscopy findings in pediatric patients with δ-PSPD.
Main Methods:
- Retrospective review of 105 pediatric patients diagnosed with δ-PSPD (2008-2010).
- Analysis of PFA-100® closure times (C-EPI and C-ADP) in 99 patients.
- Correlation analysis (Spearman's Rho) between PFA-100® results and average platelet granule counts from electron microscopy.
Main Results:
- 46% of tested patients had at least one abnormal PFA-100® closure time; 16% had both abnormal.
- No statistical correlation was found between C-EPI closure time and granule count (ρ = -0.0095, P = 0.9328).
- No statistical correlation was found between C-ADP closure time and granule count (ρ = 0.0315, P = 0.7798).
Conclusions:
- The PFA-100® does not correlate with the presence or severity of δ-PSPD.
- Platelet electron microscopy remains the gold standard for diagnosing δ-PSPD.
- PFA-100® testing alone is insufficient to rule out δ-PSPD in patients with suspected bleeding disorders.

